BNBX Key Statistics, Chart & Performance
The current stock price of BNBX is 2.6 USD. In the past month the price decreased by -29.16%.
BNBX Latest News, Press Relases and Analysis
BNBX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 26.38 | 221.98B | ||
| DHR | DANAHER CORP | 29.41 | 160.19B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 186.73 | 56.74B | ||
| A | AGILENT TECHNOLOGIES INC | 27.51 | 43.52B | ||
| IQV | IQVIA HOLDINGS INC | 19.78 | 39.17B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.29 | 30.17B | ||
| WAT | WATERS CORP | 31.77 | 24.02B | ||
| ILMN | ILLUMINA INC | 30.15 | 20.09B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 39.21 | 19.95B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.43 | 16.69B | ||
| TEM | TEMPUS AI INC | N/A | 13.86B | ||
| RVTY | REVVITY INC | 21.8 | 11.84B |
Related stock screener links
About BNBX
Company Profile
Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 46 full-time employees. The company went IPO on 2001-08-24. The firm is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The firm operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Company Info
BNB PLUS CORP
50 Health Sciences Drive
Stony Brook NEW YORK US
Employees: 46
Phone: 16312408800
BNB PLUS CORP / BNBX FAQ
Can you describe the business of BNB PLUS CORP?
Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 46 full-time employees. The company went IPO on 2001-08-24. The firm is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The firm operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
What is the stock price of BNB PLUS CORP today?
The current stock price of BNBX is 2.6 USD. The price increased by 4.42% in the last trading session.
Does BNB PLUS CORP pay dividends?
BNBX does not pay a dividend.
What is the ChartMill rating of BNB PLUS CORP stock?
BNBX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for BNB PLUS CORP?
BNB PLUS CORP (BNBX) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Can you provide the market cap for BNB PLUS CORP?
BNB PLUS CORP (BNBX) has a market capitalization of 11.31M USD. This makes BNBX a Nano Cap stock.
BNBX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BNBX.
BNBX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BNBX. BNBX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
BNBX Financial Highlights
Over the last trailing twelve months BNBX reported a non-GAAP Earnings per Share(EPS) of -924.25. The EPS increased by 89.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -679.56% | ||
| ROE | -929.59% | ||
| Debt/Equity | 0 |
BNBX Forecast & Estimates
For the next year, analysts expect an EPS growth of 92.97% and a revenue growth 50.26% for BNBX